前列腺癌,prostate cancer
1)prostate cancer前列腺癌
1.Improved synthesis of 17-(5′-isoxazolyl) androst-4,16-dien-3-one,a potential agent for the treatment of prostate cancer;新的前列腺癌治疗剂17-( 5′-异噁唑基 )雄甾-4,16-二烯-3-酮合成方法的改进(英文)
2.Establishment and application of transplantable TRAMP-C2 prostate cancer mice model;TRAMP-C2可移植前列腺癌动物模型的建立及初步应用
3.The Differential and Diagnostic Value for Prostate Cancer of the Serum Free PSA and Total PSA and Their Ratio;血清游离PSA与总PSA及其比值对前列腺癌的鉴别诊断价值
英文短句/例句

1.To Study the Expression of CD133 in Prostate Tissues,the Tissues of Hyperplasia of Prostate Gland and Prostatic Carcinoma Tissues;CD133在前列腺/前列腺增生/前列腺癌中的表达
2.Prostate MRS in the Diagnosis of Peripheral Zone Prostate Cancer前列腺MRS诊断外周带前列腺癌的价值
3.Prostatic Zn Determination for Prostate Cancer Diagnostic Value前列腺组织锌对前列腺癌的诊断价值
4.Prostate cancer grows slowly.前列腺癌发展比较缓慢,
5.The Expression of Prostasin in Prostate Carcinoma;Prostasin在前列腺癌中的表达
6.And extremely inhomogenous echo was found in 13 carcinomas (81.25%) and 5hyperplasias (13.16%).前列腺癌患者前列腺内回声极不均匀者占81.25%,前列腺增生者占13.16%。
7.Magnetic Resonance Imaging Study on Normal Prostate、Benign Prostatic Hyperplasia and Prostatic Carcinoma;正常前列腺、良性前列腺增生及前列腺癌的磁共振成像研究
8.Prostatic Zinc Combined with Prostate-specific Antigen for Prostate Cancer Diagnostic Research前列腺组织锌联合前列腺特异性抗原对前列腺癌诊断的研究
9.Microcirculation changes in benigh prostatic hyperplasia and prostatic carcinoma前列腺增生症和前列腺癌的前列腺组织微循环改变
10.The Value of MRI、MRS in Combination with PSA in the Differentiation of Prostate Carcinoma and Benign Prostate HyperplasiaMRI、MRS联合PSA鉴别前列腺癌和前列腺增生的价值
11.Marker Screening of the Early Diagnosis of Prostate Cancer in Prostatic Fluid前列腺液中前列腺癌早期诊断标记物的筛选
12.The clinic research of prostate puncture on pathological diagnosis of prostate cancer前列腺穿刺活检诊断前列腺癌的临床病理研究
13.Evaluation of MRI and MRS in the diagnosis of prostatic cancer and benign prostatic hyperplasiaMRI、MRS对鉴别前列腺癌和前列腺增生的诊断价值
14.Clinical Value of Examination in the Diagnosis of Prostate Carcinoma前列腺集团检查对诊断前列腺癌的临床价值
15.The expression of PCA3 mRNA in urine sediments obtained after prostatic massage of patients with prostate cancerPCA3在前列腺癌患者前列腺按摩后尿液中的表达
16.Removing a cancerous prostate gland reduces the chance of dying from prostate caner.割除癌变的前列腺可以降低因患前列腺癌而死亡的几率。
17.Extraperitoneal laparoscopic radical prostatectomy for localized prostate cancer (a report of 15 cases)经腹膜外腹腔镜前列腺癌根治术治疗局限性前列腺癌(附15例报告)
18.Well, you don't want me to develop prostate cancer, do you?哎呀,你也不希望我患前列腺癌,是吧?
相关短句/例句

prostate carcinoma前列腺癌
1.Morphological expression of glutathione S-transferase P1 in prostate carcinoma;谷光甘肽S-转移酶在前列腺癌中的形态学表达
2.The relationship between neuroendocrine differentiated prostate carcinoma and drug-resistance to endocrine therapy;前列腺癌神经内分泌化与内分泌治疗耐药的关系
3.Toxic effects of CD-TK double suicidal gene system against prostate carcinoma cells;CD-TK双自杀基因系统对前列腺癌细胞的杀伤作用
3)prostatic carcinoma前列腺癌
1.Relationship between prostatic carcinoma label matter and diet formation;前列腺癌标志物与年龄及膳食结构关系
2.Diagnostic value on prostatic carcinoma by transrectal color Doppler flow imaging;经直肠彩色多普勒超声对前列腺癌的诊断研究
3.The expression of p53 and VEGF in human prostatic carcinoma and their clinical significances;p53和VEGF在前列腺癌组织中的表达及临床意义
4)Prostatic cancer前列腺癌
1.Detection of prostate stem cell antigen and serum prostate specific antigen of patients with prostatic cancer;前列腺癌患者癌组织前列腺干细胞抗原、血清前列腺特异抗原检测
2.Changes of Androgen Receptor Expression in Hormonal Dependent Prostatic Cancer and Hormonal Independent Prostatic Cancer;雄激素依赖性和非依赖性前列腺癌雄激素受体表达水平的变化
3.Value of prostate specific antigen in early diagnosis of prostatic cancer;前列腺特异性抗原对前列腺癌早期诊断的价值
5)prostate adenocarcinoma前列腺癌
1.Methods The expression of PSA was analysed by using ABC immunohistochemical staining in Prostate adenocarcinomas.目的 探讨血清和组织中前列腺特异性抗原 (PSA )的表达水平 ,与前列腺癌 (Pca)组织学分级的相关性。
2.Background: Prostate adenocarcinoma is one of the major malignancies of the genitourinary system.背景和目的:前列腺腺癌(以下简称前列腺癌)是泌尿生殖系统的主要恶性肿瘤之一。
6)Prostate cancer前列腺腺癌
1.BackgroundWhile the androgen-dependence of the prostate gland has been accepted, the participation of estrogen,mediated via the estrogen receptors in the pathogenesis of benign prostatic hyperplasia (BPH) and prostate cancer(Pca)have only recently been recognized.对于ERα与良性前列腺增生症(BPH)、前列腺腺癌(Pca)的关系,各家研究结果也不尽相同。
2.Prostate cancer, N-SCLC with NED had a lot of difference with the others in a variety of biological behavior of tumor.这些伴NED的前列腺癌、肺非小细胞癌(NSCLC)在生物学行为上与其它肿瘤有很大的差别,其形态相似于肺的小细胞癌,但常伴有前列腺腺癌、肺腺、鳞癌的成分,这可能与患者的预后有关。
延伸阅读

前列腺癌前列腺癌prostaticcarcinoma发生在前列腺的恶性肿瘤。男性常见的肿瘤。多发生在50岁以上,发病率随年龄而增长。前列腺癌的发展受性激素的影响,雄激素促使其生长,血清酸性磷酸酶增高和雌激素对其有抑制作用。前列腺癌分为7期:A1、A2、B1、B2、C、D1、D2期。临床表现主要为排尿梗阻症状,如排尿发动慢,尿流细及夜尿多。不并发前列腺增生者可无排尿梗阻症状。约5%患者以转移癌为主诉症状,如骨转移引起局部疼痛,肝转移可查到上腹部肿块,晚期可有左锁骨上淋巴结肿大、咳嗽、胸痛等。诊断时首先为直肠指检发现肿瘤,继以组织活检证实,其余方法在于肯定肿瘤分期以便选择治疗方案。摄制胸、腹及盆腔X射线平片有助诊断。骨骼X射线检查包括骨盆、腰椎及股骨,多数为生骨性变化,骨质阴影密度增大,骨小梁消失。使用85Sr及99mTc作骨扫描比X射线检查更为准确。从会阴部作前列腺穿刺活检,阳性率可达70%~80%,亦可经直肠穿刺针吸细胞学检查。血清酸性磷酸酶测定对前列腺癌的诊断甚为重要。超声声像图、CT及磁共振(MRI)对诊断均有一定作用。淋巴系统造影术一般不用作前列腺癌的常规检查。治疗根据分期选择疗法,如根治手术、放射疗法、激素和化学疗法等。